This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Aug. 20 Premarket Briefing: 10 Things You Should Know

NEW YORK (TheStreet) -- Here are 10 things you should know for Wednesday, Aug. 20:

1. -- U.S. stock futures were mixed early Wednesday ahead of minutes from the latest meeting of the Federal Reserve's policy-making committee.

European stocks pared gains accrued earlier this week as investors focused on the Federal Reserve's next move and as German price data pointed to subdued growth.

Stock in Tokyo and Hong Kong rose.

Read More: Clinton's Wild Idea for Bank Fines Makes Perfect Sense

2. -- The economic calendar in the U.S. on Wednesday includes the minutes from the July meeting of the Federal Open Market Committee at 2 p.m. EDT.

3. -- U.S. stocks on Tuesday stretched out early gains to the close on Tuesday, with the S&P 500 gaining 2.66% in so far in August, The gains came as many economists and market participants continued to bet that the Federal Reserve will keep communicating a more dovish stance despite rising chatter on inflation and a consistently healthy economic recovery.

The Dow Jones Industrial Average rose 0.48% to close at 16,919.59. The S&P 500 gained 0.5% to 1,981.60. The Nasdaq rose 0.43% to 4,527.51.

4. -- Allergan (AGN) approached Salix Pharmaceuticals (SLXP) and at least one other company about a potential acquisition, as the Botox maker seeks to fend off a $53 billion hostile takeover from Valeant Pharmaceuticals (VRX) , The Wall Street Journal reported, citing people familiar with the matter.

While it's unclear where the talks stand, Allergan could strike a takeover deal with Salix or another unknown party as early as next month, one of the people told the Journal.

Valeant in April teamed up with activist investor William Ackman, who owns a big stake in Allergan, to pursue a cash-and-stock takeover of the company. 

5. -- Citigroup (C - Get Report) is considering selling its consumer-banking business in Japan, two people with knowledge of the matter told Bloomberg.

The bank, which earns the most international revenue of any U.S. lender, has begun approaching Japanese firms including the three largest lenders, trust banks and regional lenders to gauge their interest, one of the people said. Citigroup could start a bidding process next month, the people told Bloomberg.

Citigroup's 33 branches in Japan represent less than 1% of its global total, according to Bloomberg.

6. -- Hewlett-Packard (HPQ - Get Report) is expected by Wall Street on Wednesday to report fiscal third-quarter earnings of 89 cents a share on revenue of $27 billion.

HP continues to remake itself under CEO Meg Whitman, slashing costs and boosting sales of personal computers.

HP's largest segment by revenue remains personal computers, with sales in its personal systems group growing 7% in the fiscal second quarter from a year earlier.

7. -- Lowe's (LOW)   posted second-quarter earnings of $1.04 a share on sales of $16.6 billion, up from year-earlier sales of $15.7 billion.

Analysts expected the home-improvement retailer and chief rival to Home Depot (HD) to report second-quarter earnings of $1.02 a share on revenue of $16.55 billion.

Lowe's reduced its forecast for sales in fiscal 2014, saying it expects total sales to rise 4.5%; it previously estimated sales growth of 5%.

Read More: Lowe's Will Never Stop Improving and Remains a Strong Buy

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
C $53.73 0.45%
HPQ $34.57 -1.00%
AAPL $129.36 0.21%
FB $79.60 -0.19%
GOOG $573.64 0.40%

Markets

DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs